The Food and Drug Administration has issued a warning to a Warsaw-based orthopedic company. This comes after a recent inspection at Zimmer Biomet’s Montreal production plant, according to the Journal-Gazette. U.S. inspectors say they saw things at the plant that didn’t comply with “current good manufacturing practice requirements”. It didn’t elaborate on what those violations were in a letter sent to the Security and Exchange Commission in May. Zimmer-Biomet can still make and ship products from the Montreal factory, but applications for certain devices won’t be approved by the FDA until the issues are resolved.
